Health House International Ltd
ASX:HHI
Health House International Ltd
ASX:HHI
Price:
0.005
AUD
Market Closed
Market Cap:
AU$891.1k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Health House International Ltd
ASX:HHI
|
AU |
|
Mayfield Group Holdings Ltd
ASX:MYG
|
AU |
|
HCR Co Ltd
SSE:688500
|
CN |
|
Generation Income Properties Inc
NASDAQ:GIPR
|
US |
|
E
|
Etga Group Ltd
TASE:ETGA
|
IL |
|
C
|
Concert Pharmaceuticals Inc
F:73C
|
US |
|
Q
|
Qinchuan Machine Tool & Tool Group Share Co Ltd
SZSE:000837
|
CN |
|
S
|
Samart Aviation Solutions PCL
SET:SAV
|
TH |
|
FS Development Investment Holdings
SZSE:300071
|
CN |
|
S
|
SWS Hemodialysis Care Co Ltd
SSE:688410
|
CN |
|
Y
|
Yuanda China Holdings Ltd
HKEX:2789
|
CN |
|
J
|
Jiangxi Tianli Technology INC
SZSE:300399
|
CN |
|
S
|
SillaJen Inc
KOSDAQ:215600
|
KR |
|
B
|
Bestore Co Ltd
SSE:603719
|
CN |
|
ARE Holdings Inc
F:A19
|
JP |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of HHI.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HHI
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
HHI Competitors Multiples
Health House International Ltd Competitors
Health House International Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Health House International Ltd
ASX:HHI
|
891.1k AUD | 0 | -0.5 | -0.2 | -0.2 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
105.8B USD | 0.3 | 24.4 | 17.2 | 19.3 | |
| US |
|
Cencora Inc
NYSE:COR
|
60.3B USD | 0.2 | 37.1 | 13.2 | 16.7 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
60.7B USD | 0.2 | 37.3 | 13.2 | 16.7 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
48.7B USD | 0.2 | 29.3 | 14.2 | 18.5 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.6B AUD | 2.7 | 33.8 | 25.1 | 25.1 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
62.4B CNY | 1.4 | 16.8 | 13 | 13 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.3B CNY | 0.2 | 11 | 15 | 15 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.4B USD | 0.6 | 21.1 | 10.3 | 14.5 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
63.7B HKD | 0.1 | 8 | 0.7 | 0.8 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
